Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Storage Store in a cool dry place
Other GLP-1 receptor agonists that are FDA-approved to treat type 2 diabetes and may lead to weight loss include: Dulaglutide (Trulicity) Exenatide (Bydureon) Lixisenatide (Adlyxin) Other forms of semaglutide (Ozempic and Rybelsus) Many diabetes medications and insulin reduce blood sugars but also contribute to weight gain
Hydration Requirements Retatrutide can reduce thirst perception while simultaneously causing fluid loss through increased urination and potential GI effects
[1] GLP-1 receptor agonists (e.g., semaglutide/Wegovy, liraglutide/Saxenda): These injectable medications mimic the glucagon-like peptide-1 hormone, suppressing appetite and slowing gastric emptying
